| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.2 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.2 |